VAREX IMAGING Profit Margin 2015-2020 | VREX

Current and historical gross margin, operating margin and net profit margin for VAREX IMAGING (VREX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. VAREX IMAGING net profit margin as of March 31, 2020 is 0.58%.
VAREX IMAGING Annual Profit Margins
VAREX IMAGING Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.613B $0.781B
Varex Imaging Corporation is an innovator, designer and manufacturer of X-ray imaging components which include tubes, digital flat panel detectors and other image processing solutions. Its components are used in medical imaging as well as industrial and security imaging applications. The company operates primarily in North America, Europe and Asia. Varex Imaging Corporation is based in Salt Lake City, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.017B 33.44
Medtronic (MDT) Ireland $129.409B 21.02
Stryker (SYK) United States $72.454B 28.10
Boston Scientific (BSX) United States $53.973B 31.88
Lonza Group Ag (LZAGY) Switzerland $46.320B 0.00
Baxter (BAX) United States $43.728B 0.00
ResMed (RMD) United States $29.297B 46.24
EssilorLuxottica Societe Anonyme (ESLOY) France $28.981B 0.00
Terumo (TRUMY) Japan $28.862B 36.89
Zimmer Biomet Holdings (ZBH) United States $27.836B 17.51
Sunny Optical Technology (SNPTF) China $20.336B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.428B 0.00
Bio-Rad Laboratories (BIO) United States $15.561B 70.46
Insulet (PODD) United States $12.829B 1271.00
Shandong Weigao Medical Polymer (SHWGF) China $12.301B 0.00
Quidel (QDEL) United States $11.863B 62.77
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $7.981B 40.68
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.227B 12.93
Canopy Growth (CGC) Canada $6.779B 0.00
Hill-Rom Holdings (HRC) United States $6.471B 16.07
Haemonetics (HAE) United States $4.409B 26.48
Neogen (NEOG) United States $4.066B 67.94
GW Pharmaceuticals (GWPH) United Kingdom $3.963B 0.00
ICU Medical (ICUI) United States $3.828B 27.92
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.617B 0.00
Envista Holdings (NVST) United States $3.486B 23.77
Abcam (ABCZY) $3.456B 0.00
Agios Pharmaceuticals (AGIO) United States $3.132B 0.00
NuVasive (NUVA) United States $2.929B 23.51
National Vision Holdings (EYE) United States $2.568B 44.43
TG Therapeutics (TGTX) United States $2.157B 0.00
AtriCure (ATRC) United States $1.834B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.627B 0.00
Aphria (APHA) Canada $1.374B 0.00
NanoString Technologies (NSTG) United States $1.362B 0.00
MacroGenics (MGNX) United States $1.248B 0.00
Aurora Cannabis (ACB) Canada $1.176B 0.00
Cerus (CERS) United States $1.169B 0.00
OraSure Technologies (OSUR) United States $1.127B 226.88
Vapotherm (VAPO) United States $1.113B 0.00
Cardiovascular Systems (CSII) United States $1.075B 0.00
Meridian Bioscience (VIVO) United States $1.049B 39.50
PetIQ (PETQ) United States $1.036B 29.91
InMode (INMD) Israel $1.035B 21.86
Owens & Minor (OMI) United States $1.013B 26.80
Phibro Animal Health (PAHC) United States $0.938B 18.71
Quanterix (QTRX) United States $0.915B 0.00
Omeros (OMER) United States $0.699B 0.00
Zynex (ZYXI) United States $0.664B 57.94
Surmodics (SRDX) United States $0.643B 77.53
Eagle Pharmaceuticals (EGRX) United States $0.635B 45.48
BioLife Solutions (BLFS) United States $0.617B 175.73
LeMaitre Vascular (LMAT) United States $0.592B 36.21
Lantheus Holdings (LNTH) United States $0.536B 12.48
Viemed Healthcare (VMD) United States $0.421B 37.38
Cytosorbents (CTSO) United States $0.347B 0.00
HEXO (HEXO) $0.313B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.308B 0.00
Utah Medical Products (UTMD) United States $0.297B 25.47
Organigram Holdings (OGI) Canada $0.216B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Female Health (VERU) United States $0.192B 0.00
Fonar (FONR) United States $0.159B 14.07
Exagen (XGN) United States $0.157B 0.00
Bovie Medical (APYX) United States $0.153B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Wound Management Technologies (SMTI) United States $0.132B 0.00
Liberty Health Sciences (LHSIF) Canada $0.126B 0.00
Rockwell Medical (RMTI) United States $0.119B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.116B 0.00
Capricor Therapeutics (CAPR) United States $0.114B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Evolus (EOLS) United States $0.110B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.066B 15.34
Brainsway (BWAY) Israel $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.032B 0.00
FSD PHARMA INC (HUGE) Canada $0.032B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00